The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Objective: This systematic review and meta-analysis is aimed at assessing the risks of cardiovascular adverse events in patients with rheumatoid arthritis (RA) who have been treated with fostamatinib. Methods: The electronic databases of OVID Medline, OVID EMBASE, Cochrane Central Register of Contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuehong, Liu, Huan, Huang, Yupeng, Lin, Sang, Yin, Geng, Xie, Qibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327174/
https://www.ncbi.nlm.nih.gov/pubmed/34349639
http://dx.doi.org/10.3389/fphar.2021.632551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327174/
https://www.ncbi.nlm.nih.gov/pubmed/34349639
http://dx.doi.org/10.3389/fphar.2021.632551

Ejemplares similares